How many clinical trials are studying Irinotecan Liposome?

4 recruiting trials in our tracked data involve Irinotecan Liposome.

What conditions is Irinotecan Liposome being studied for?

In our tracked recruiting trials, Irinotecan Liposome is being studied in trials for Pancreatic Cancer, Colorectal cancer, Lung cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 3 Not applicable 1

Condition	Trials
Pancreatic Cancer	2
Colorectal cancer	1
Lung cancer	1
Metastatic Colorectal Cancer	1
Pancreatic Cancer Metastatic to Liver	1
Small Cell Lung Cancer Recurrent	1

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
NCT06531278 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer
NCT06475326 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
NCT06258642 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
NCT06341296 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location